ArticleApplied health economics and health policy2025

Evaluating the Cost-Effectiveness of Etranacogene Dezaparvovec Gene Therapy for Hemophilia B Treatment in the USA.

Jyotirmoy Sarker et al.PubMed ↗Publisher ↗

No numbers read from the abstract.